Related references
Note: Only part of the references are listed.HBP1-mediated Regulation of p21 Protein through the Mdm2/p53 and TCF4/EZH2 Pathways and Its Impact on Cell Senescence and Tumorigenesis
Yifan Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Targeting EZH2 in cancer
Kimberly H. Kim et al.
NATURE MEDICINE (2016)
Identification and validation of potential prognostic lncRNA biomarkers for predicting survival in patients with multiple myeloma
Meng Zhou et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)
Osteosarcoma treatment - Where do we stand? A state of the art review
Anja Luetke et al.
CANCER TREATMENT REVIEWS (2014)
EZH2 Is Associated with Malignant Behavior in Pancreatic IPMN via p27Kip1 Downregulation
Hideyuki Kuroki et al.
PLOS ONE (2014)
Inhibitors of enhancer of zeste homolog 2 (EZH2) activate tumor-suppressor microRNAs in human cancer cells
S. Hibino et al.
ONCOGENESIS (2014)
Down-regulation of Long Non-coding RNA TUG1 Inhibits Osteosarcoma Cell Proliferation and Promotes Apoptosis
Qiang Zhang et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
Suppression of progenitor differentiation requires the long noncoding RNA ANCR
Markus Kretz et al.
GENES & DEVELOPMENT (2012)
EZH2 Promotes Expansion of Breast Tumor Initiating Cells through Activation of RAF1-β-Catenin Signaling
Chun-Ju Chang et al.
CANCER CELL (2011)
Osteosarcoma Incidence and Survival Rates From 1973 to 2004 Data From the Surveillance, Epidemiology, and End Results Program
Lisa Mirabello et al.
CANCER (2009)
Roles of the EZH2 histone methyltransferase in cancer epigenetics
Jeffrey A. Simon et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2008)
Osteosarcoma (Osteogenic sarcoma)
Piero Picci
ORPHANET JOURNAL OF RARE DISEASES (2007)
Immunohistochemical analysis of pRb2/p130, VEGF, EZH2, p53, p16(INK4A), p27(KIP1), p21(WAF1), Ki-67 expression patterns in gastric cancer
Eliseo Mattioli et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
Immunohistochemical evaluation of pRb2/p130, VEGF, EZH2, p53, p16, p21waf-1, p27, and PCNA in Barrett's esophagus
E Merola et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells
CG Kleer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The polycomb group protein EZH2 is involved in progression of prostate cancer
S Varambally et al.
NATURE (2002)
Share Paper
